Jonathan Rubin - 25 Feb 2026 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
SVP, Chief Medical Officer
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
25 Feb 2026
Net transactions value
-$34,216
Form type
4
Filing time
26 Feb 2026, 16:17:42 UTC
Previous filing
25 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Jonathan Rubin filed Form 4 for SUPERNUS PHARMACEUTICALS, INC. (SUPN) on 26 Feb 2026."

Quick Takeaways

  • This page summarizes Jonathan Rubin's Form 4 filing for SUPERNUS PHARMACEUTICALS, INC. (SUPN).
  • 3 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 26 Feb 2026, 16:17.

What Changed

  • Previous filing in this sequence was filed on 25 Feb 2026.
  • Current net transaction value: -$34,216.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rubin Jonathan SVP, Chief Medical Officer C/O SUPERNUS PHARMACEUTICALS, INC.,, 9715 KEY WEST AVENUE, ROCKVILLE /s/ Timothy C. Dec, as attorney-in-fact 26 Feb 2026 0001836067

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Award $0 +1,250 +9.8% $0.000000 14,016 25 Feb 2026 Direct
transaction SUPN Common Stock Tax liability $34,216 -675 -4.8% $50.69 13,341 25 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Restricted Stock Unit Disposed to Issuer $0 -1,250 -50% $0.000000 1,250 25 Feb 2026 Common Stock 1,250 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.
F2 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F3 These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024.

Sponsored